Men with high-risk prostate cancer have a higher likelihood of residual disease after prostatectomy and may require radiation ...

A prespecified analysis of a phase 3 trial evaluated the ability of PAM50 molecular prostate cancer subtypes to predict benefit from salvage treatment intensification.

Case report highlights the importance of a multidisciplinary, evidence-based approach to treating prostate cancer that ...

A recent analysis of the NRG-RTOG 0534 "SPPORT" clinical trial evaluated the Luminal B (LumB) molecular subtype using the ...

Five-year phase 3 results support hypofractionated radiotherapy as a shorter treatment option after prostatectomy but raise concern about late GU toxicity.

A simple PSA blood test can help detect prostate cancer, but an elevated PSA does not necessarily mean cancer, according to doctors.

Men with high-risk prostate cancer have a higher likelihood of having residual disease following prostatectomy and may require radiation therapy after surgery, particularly when PSA levels begin to ...

For the hundreds of thousands of men who undergo radical prostatectomy each year, one question looms over every postoperative ...

Prostate cancer has a well-earned reputation for being one of the more trackable malignancies in medicine. Since the mid-1980s, a single blood test measuring prostate-specific antigen, or PSA, has ...

Being told your "PSA is high" makes you feel anxious, doesn't it?Perhaps the first thing you want to know is,"Does this mean ...